Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Shareholders Equity (Quarterly) : 18.85B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.85B |
| March 31, 2026 | 18.65B |
| December 31, 2025 | 18.26B |
| September 30, 2025 | 18.21B |
| June 30, 2025 | 17.63B |
| March 31, 2025 | 16.98B |
| December 31, 2024 | 16.72B |
| September 30, 2024 | 16.36B |
| June 30, 2024 | 15.89B |
| March 31, 2024 | 15.21B |
| December 31, 2023 | 14.80B |
| September 30, 2023 | 14.48B |
| June 30, 2023 | 14.47B |
| March 31, 2023 | 13.80B |
| December 31, 2022 | 13.40B |
| September 30, 2022 | 12.78B |
| June 30, 2022 | 11.87B |
| March 31, 2022 | 11.24B |
| December 31, 2021 | 10.90B |
| September 30, 2021 | 10.43B |
| June 30, 2021 | 10.75B |
| March 31, 2021 | 10.68B |
| December 31, 2020 | 10.70B |
| September 30, 2020 | 10.76B |
| June 30, 2020 | 11.31B |
| Date | Value |
|---|---|
| March 31, 2020 | 12.55B |
| December 31, 2019 | 13.34B |
| September 30, 2019 | 14.00B |
| June 30, 2019 | 12.95B |
| March 31, 2019 | 13.83B |
| December 31, 2018 | 13.04B |
| September 30, 2018 | 13.77B |
| June 30, 2018 | 12.26B |
| March 31, 2018 | 14.05B |
| December 31, 2017 | 12.61B |
| September 30, 2017 | 12.86B |
| June 30, 2017 | 11.59B |
| March 31, 2017 | 11.48B |
| December 31, 2016 | 12.14B |
| September 30, 2016 | 12.12B |
| June 30, 2016 | 11.40B |
| March 31, 2016 | 10.33B |
| December 31, 2015 | 9.373B |
| September 30, 2015 | 10.57B |
| June 30, 2015 | 12.57B |
| March 31, 2015 | 11.67B |
| December 31, 2014 | 10.81B |
| September 30, 2014 | 10.43B |
| June 30, 2014 | 9.561B |
| March 31, 2014 | 9.137B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 439.74M |
| AbbVie, Inc. | -5.935B |
| Gilead Sciences, Inc. | 11.83B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Amgen, Inc. | 11.69B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.09B |
| Total Liabilities (Quarterly) | 13.24B |
| Debt to Equity Ratio | 0.4433 |
| Current Ratio | 1.865 |
| Net Debt Paydown Yield | -1.09% |